Dr. Koen Deloose describes his algorithmic approach to treating a patient with chronic limb-threatening ischemia and a nonhealing ulcer, with discussion from Drs. Katherine McMackin and Constantino ...
Improving recognition and outcomes in pelvic venous disease through embolization, with case examples. Gloria Salazar, MD, ...
The abstract, titled “What PET/CT Reveals After Transarterial Microperfusion for Pancreatic Cancer,” was submitted by a multidisciplinary team of cancer experts, including Dr. Mustafa Al-Roubaie, an ...
London, UK – Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036 says Visiongain, in the newly released report entitled Ophthalmic Drugs Market Report ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Eylea (aflibercept 8mg, 114.3 ...
The MHRA has granted marketing authorisation for Eylea® (aflibercept 8 mg) for the treatment of patients with macular oedema following retinal vein occlusion (RVO) including branch, central and ...
After undergoing medical evaluation and treatment at the Pakistan Institute of Medical Sciences for central retinal vein occlusion, here is more to know ...
ISLAMABAD: Pakistan's incarcerated former prime minister Imran Khan on early Tuesday was taken from jail to a hospital here for treatment of an eye ailment and later shifted back, officials said. Khan ...
Pakistan’s incarcerated former prime minister Imran Khan on early Tuesday was taken from jail to a hospital here for treatment of an eye ailment and later shifted back, officials said. Khan was ...
Imran Khan receives eye treatment in Islamabad, while his party demands transparency regarding his medical care amid ongoing ...
Former Pakistan PM Imran Khan was shifted back to the Adiala Jail after his treatment in Pakistan Institute of Medical Sciences (PIMS) at Islamabad.
A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...